High materiality7/10
Definium Therapeutics price target raised to $55 from $50 at Maxim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Maxim Group raises DFTX target to $55 from $50; current price $42.88, implying upside potential.
- Target rises to $55; price $42.88.
Key facts
- 01
Target: $55
- 02
Posted price: $42.88
- 03
Analyst firm: Maxim Group
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.